Multiechinocandin- and Multiazole-ResistantCandida parapsilosisIsolates Serially Obtained during Therapy for Prosthetic Valve Endocarditis
Top Cited Papers
Open Access
- 1 February 2005
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 49 (2) , 767-769
- https://doi.org/10.1128/aac.49.2.767-769.2005
Abstract
Echinocandins are approved for the treatment of candidal infections. In vitro they have been shown to be less potent against strains of Candida parapsilosis than against other Candida spp. This is the first case report describing the development of a secondary multidrug (echinocandin-azole)-resistant Candida strain during therapy.Keywords
This publication has 21 references indexed in Scilit:
- In Vitro Activity of Micafungin (FK-463) against Candida spp.: Microdilution, Time-Kill, and Postantifungal-Effect StudiesAntimicrobial Agents and Chemotherapy, 2002
- In Vitro Activity of Caspofungin (MK-0991) against Candida albicans Clinical Isolates Displaying Different Mechanisms of Azole ResistanceJournal of Clinical Microbiology, 2002
- Trends in Antifungal Susceptibility of Candida spp. Isolated from Pediatric and Adult Patients with Bloodstream Infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000Journal of Clinical Microbiology, 2002
- Randomized, Double-Blind, Multicenter Study of Caspofungin versus Amphotericin B for Treatment of Oropharyngeal and Esophageal CandidiasesAntimicrobial Agents and Chemotherapy, 2002
- Caspofungin: pharmacology, safety and therapeutic potential in superficial and invasive fungal infectionsExpert Opinion on Investigational Drugs, 2001
- In vitro activity of a new echinocandin, LY303366, and comparison with fluconazole, flucytosine and amphotericin B against Candida species† †This study was presented, in part, at the 37th ICAAC in Toronto, Canada, 28th September – 1st October 1997.Clinical Microbiology & Infection, 2001
- Structure–activity relationships of ketolides vs. macrolidesClinical Microbiology & Infection, 2001
- Discovery of Novel Antifungal (1,3)-β- d -Glucan Synthase InhibitorsAntimicrobial Agents and Chemotherapy, 2000
- An outbreak of Candida parapsilosis prosthetic valve endocarditisDiagnostic Microbiology and Infectious Disease, 1997
- Effects of Sub‐Inhibitory Concentrations of Antifungal Agents on Adherence of Candida spp. to Buccal Epithelial Cells in Vitro: Die Wirkung subinhibitorischer Antimyzetika‐Konzentrationen auf die Adharenz von Candida‐Arten an Epithelzellen der MundschleimhautMycoses, 1989